A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
Titel:
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
Auteur:
Glimelius, B. Sørbye, H. Balteskard, L. Byström, P. Pfeiffer, P. Tveit, K. Heikkilä, R. Keldsen, N. Albertsson, M. Starkhammar, H. Garmo, H. Berglund, Å.